PRO Test runs one of Europe's longest-standing drug-checking operations, pulling in samples from testing sites and services across the continent and publishing what they find every week. The week 43 report, out November 10, is a useful gut check for anyone who's been on a floor this autumn.
Are pills actually getting stronger?
Yes, at least this week. The typical MDMA pill tested came in at 166mg, compared with a 156mg average across the last twelve months. Half the samples PRO Test logged fell between 144.5mg and 168.5mg, so the spread is real, not a single outlier skewing the number. For context: 156mg was already enough to floor plenty of first-timers. An extra 10mg on top, repeated across a weekend, is the kind of margin that turns a fun night into an ambulance call, especially for anyone redosing because the first pill "didn't feel strong enough."
What's actually hiding inside the "MDMA" you bought?
The more persistent problem is PMMA, a chemical cousin of MDMA that hits slower and is considerably more dangerous at the doses people take thinking it's ecstasy. PRO Test's data shows it still circulating under a rotating cast of pill stamps: Trump, Gorilla, Red Bull, Club 555, Mitsubishi and Scorpion. Back in August, the Netherlands' Trimbos Institute put out a Red Alert specifically over Trump-shaped pills found loaded with PMMA, warning that because it works slower than MDMA, people take a second pill assuming the first was weak, then overheat badly on the combined dose.
The stamp tells you nothing. The same logo has shipped as pure MDMA and as PMMA-laced product in the same season. Worse, a basic reagent test, the kind sold cheaply as a harm-reduction kit, can read "positive for MDMA" on a pill that also contains PMMA, because the test isn't built to flag the second compound once MDMA is present. PRO Test is blunt about this: catching PMMA reliably needs lab analysis or a TLC purity test, not a color-change kit in a baggie.
Reagent tests alone cannot identify PMMA when it is mixed with MDMA.
What was the Zurich sample that wasn't what it was sold as?
The starkest single result in the report: a sample bought and sold as mescaline in Zurich, collected October 20, tested at 91.7% pure ketamine. Not a mescaline analog, not mescaline cut with something else. Ketamine, full stop, sold under a completely different drug's name. Anyone dosing for a psychedelic experience and getting a dissociative at that purity is getting a radically different night than the one they planned for, with its own risks around motor control and awareness that have nothing to do with what mescaline would do.
Why it matters
The scene's harm-reduction infrastructure, PRO Test, checkit! in Vienna, saferparty.ch in Switzerland and similar services elsewhere, exists precisely because pill stamps and dealer reassurances are not reliable information. This week's numbers are the proof: strength is drifting up, PMMA is still being sold as MDMA under half a dozen familiar logos, and at least one psychedelic buyer in Zurich walked away with a ketamine dose instead.
What we think
Nobody at TTH is telling anyone what to put in their body. But if you're going to, use the testing services that exist for exactly this, and don't trust a stamp just because you've seen it before. This week's data shows the same stamp can mean two completely different drugs depending on the batch.
FAQ
Is PMMA the same thing as MDMA?
No. PMMA (para-methoxymethylamphetamine) is a different compound that produces a slower, weaker initial rush than MDMA but carries a much higher overdose and overheating risk, which is exactly why people who redose thinking the first pill was weak get into trouble.
Can a home reagent testing kit catch PMMA?
Not reliably once MDMA is also present in the pill. PRO Test says lab analysis or a TLC (thin-layer chromatography) purity test is needed to separate the two; a basic color-change reagent kit can still read positive for MDMA and miss the PMMA entirely.
Where can someone actually get a pill tested in Europe?
Services like PRO Test, Austria's checkit!, and Switzerland's saferparty.ch run walk-in or postal testing at festivals, fixed sites or by mail in several European countries, and publish their aggregate findings, like the week 43 report, for anyone to check.
